Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/34854909/ below:

Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance

Affiliations

• ¹ Division of General Internal Medicine, University of Michigan, Ann Arbor.
• ² IBM Watson Health, Cambridge, Massachusetts.
• ³ Exact Sciences Corporation, Madison, Wisconsin.
• ⁴ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

• PMID: 34854909
• PMCID: PMC8640889
• DOI: 10.1001/jamanetworkopen.2021.36798

Item in Clipboard

A Mark Fendrick et al. JAMA Netw Open. 2021.

• ¹ Division of General Internal Medicine, University of Michigan, Ann Arbor.
• ² IBM Watson Health, Cambridge, Massachusetts.
• ³ Exact Sciences Corporation, Madison, Wisconsin.
• ⁴ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.

• PMID: 34854909
• PMCID: PMC8640889
• DOI: 10.1001/jamanetworkopen.2021.36798

Item in Clipboard

This economic evaluation examines whether adult patients in the US who have commercial or Medicare insurance pay out-of-pocket costs associated with follow-up colonoscopy within 6 months of a noninvasive stool-based test.

PubMed Disclaimer

Conflict of Interest Disclosures: Dr Fendrick reported serving as a consultant for AbbVie, Amgen, Bayer, Centivo, Community Oncology Association, Covered California, Eli Lilly and Company, EmblemHealth, Exact Sciences Corporation, Freedman HealthCare, GRAIL, Harvard University, Health & Wellness Innovations, Health at Scale Technologies, HealthCorum, Hygieia, Mallinckrodt Pharmaceuticals, MedZed, Merck & Co, Mercer, Montana Health CO-OP, Pair Team, Penguin Pay, Phathom Pharmaceuticals, Risalto Health, Risk International, Sempre Health, state of Minnesota, US Department of Defense, Virginia Center for Health Innovation, Wellth, Wildflower Health, Yale New Haven Health System, and Zansors; reported receiving research support from the Agency for Healthcare Research and Quality, Boehringer Ingelheim, Gary and Mary West Health Policy Center, Arnold Ventures, the Laura and John Arnold Foundation, National Pharmaceutical Council, Patient-Centered Outcomes Research Institute, Pharmaceutical Research and Manufacturers of America, the Robert Wood Johnson Foundation, Michigan Department of Health and Human Services, and Centers for Medicare & Medicaid Services; and reported serving as coeditor of the American Journal of Managed Care , a member of the Medicare Evidence Development & Coverage Advisory Committee, and a partner in V-BID Health. Mss Princic and Wilson reported being employed by IBM Watson Health, which received funding from Exact Sciences Corporation to conduct this study. Dr Miller-Wilson reported being employed by Exact Sciences Corporation. Dr Limburg reported serving as chief medical officer for screening at Exact Sciences Corporation through a contracted services agreement with Mayo Clinic; Dr Limburg and Mayo Clinic have contractual rights to receive royalties through this agreement.

• Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.

  Ladabaum U, Mannalithara A, Brill JV, Levin Z, Bundorf KM. Ladabaum U, et al. Am J Gastroenterol. 2018 Dec;113(12):1836-1847. doi: 10.1038/s41395-018-0106-8. Epub 2018 Jun 15. Am J Gastroenterol. 2018. PMID: 29904156 Free PMC article.

• The value of colonoscopic colorectal cancer screening of adults aged 50 to 64.

  Fitch K, Pyenson B, Blumen H, Weisman T, Small A. Fitch K, et al. Am J Manag Care. 2015 Jul 1;21(7):e430-8. Am J Manag Care. 2015. PMID: 26295271

• The value of colonoscopy.

  Allen JI. Allen JI. Gastroenterology. 2014 Feb;146(2):573-5. doi: 10.1053/j.gastro.2013.12.001. Gastroenterology. 2014. PMID: 24579094 No abstract available.

• Impact of comorbidity on colorectal cancer screening cost-effectiveness study in diabetic populations.

  Dinh TA, Alperin P, Walter LC, Smith R. Dinh TA, et al. J Gen Intern Med. 2012 Jun;27(6):730-8. doi: 10.1007/s11606-011-1972-6. Epub 2012 Jan 12. J Gen Intern Med. 2012. PMID: 22237663 Free PMC article. Review.

• Screening for Colorectal Cancer.

  Montminy EM, Jang A, Conner M, Karlitz JJ. Montminy EM, et al. Med Clin North Am. 2020 Nov;104(6):1023-1036. doi: 10.1016/j.mcna.2020.08.004. Med Clin North Am. 2020. PMID: 33099448 Review.

• Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening Test.

  Fendrick AM, Lieberman D, Chen JV, Vahdat V, Ozbay AB, Limburg PJ. Fendrick AM, et al. Cancer Res Commun. 2023 Oct 17;3(10):2113-2117. doi: 10.1158/2767-9764.CRC-23-0322. Cancer Res Commun. 2023. PMID: 37787758 Free PMC article.

• Exploring factors influencing decision making for colonoscopy in first-degree relatives of patients with colorectal cancer: a mixed-methods study.

  Chen H, Jiang Y, Wang J, Tang C, Pan X, Zhang W, Zheng S, Zhong J, Feng B. Chen H, et al. BMC Public Health. 2025 Feb 25;25(1):773. doi: 10.1186/s12889-025-21820-6. BMC Public Health. 2025. PMID: 40001012 Free PMC article.

• Reducing disparities and achieving health equity in colorectal cancer screening.

  Segura A, Siddique SM. Segura A, et al. Tech Innov Gastrointest Endosc. 2023;25(3):284-296. doi: 10.1016/j.tige.2023.02.007. Epub 2023 Mar 1. Tech Innov Gastrointest Endosc. 2023. PMID: 37808233 Free PMC article.

• Comparison of Screening Colonoscopy Rates After Positive Noninvasive Testing for Colorectal Cancer in States With and Without Cost-Sharing.

  Barthold D, Yeung K, Lieberman D, Fendrick AM. Barthold D, et al. JAMA Netw Open. 2022 Jun 1;5(6):e2216910. doi: 10.1001/jamanetworkopen.2022.16910. JAMA Netw Open. 2022. PMID: 35699960 Free PMC article.

• Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population.

  Fendrick AM, Lieberman D, Vahdat V, Chen JV, Ozbay AB, Limburg PJ. Fendrick AM, et al. Cancer Prev Res (Phila). 2022 Oct 4;15(10):653-660. doi: 10.1158/1940-6207.CAPR-22-0153. Cancer Prev Res (Phila). 2022. PMID: 35768200 Free PMC article.

1. 1. Zauber AG, Winawer SJ, O’Brien MJ, et al. . Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687-696. doi:10.1056/NEJMoa1100370 - DOI - PMC - PubMed
2. 1. Shaukat A, Mongin SJ, Geisser MS, et al. . Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369(12):1106-1114. doi:10.1056/NEJMoa1300720 - DOI - PubMed
3. 1. Davidson KW, Barry MJ, Mangione CM, et al. ; US Preventive Services Task Force . Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238 - DOI - PubMed
4. 1. Pan Foundation . Issue brief No. 15: food insecurity among older adults. January 2021. Accessed June 6, 2021. https://www.panfoundation.org/app/uploads/2021/02/PAN-Issue-Brief-15.pdf
5. 1. McBain RK, Cantor JH, Jena AB, Pera MF, Bravata DM, Whaley CM. Decline and rebound in routine cancer screening rates during the COVID-19 pandemic. J Gen Intern Med. 2021;36(6):1829-1831. doi:10.1007/s11606-021-06660-5 - DOI - PMC - PubMed

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3